Treatment of Vaginal Cancer Presenting with Widespread Distant Metastatic Disease in Medically Fit Patients
Clinical Scenario
This protocol addresses vaginal cancer diagnosed at a stage when widespread distant metastatic disease is already present at initial presentation, in patients who are medically fit to receive systemic treatment. The extent of spread and the patient's overall fitness are central to selecting the appropriate management strategy.
Specific Considerations
In this scenario, the presence of widespread distant metastases at presentation defines a high-disease-burden situation. The patient's fitness status and any prior oncologic treatment history, performance status, and associated comorbidities all influence which agents are appropriate. Pelvic disease and bone metastases may require additional symptom-directed interventions alongside systemic treatment.
Treatment Approach (overview)
The recommended systemic approach involves platinum-based combination therapy, drawing on regimens established for closely related gynecological cancers. Alongside systemic treatment, targeted palliative interventions may be considered for local symptom control.
The full regimen — including agent selection criteria, sequencing, and management of obstructive or bleeding complications — is available in the complete structured protocol.
References
DOI: 10.1016/j.radonc.2023.109662
- In medically fit patients with widespread distant metastatic disease at presentation, platinum-based systemic combination therapy, equivalent to cervical cancer regimens, is recommended [IV, A].
- Selection of cytotoxic agents depends on the previous oncologic treatment, performance status and associated co-morbidities [IV, B].
- Palliative radiotherapy (single fraction/short course) to control bleeding, discharge, and pain due to pelvic disease or bone metastases should be considered [IV, A].
- Surgical interventions including diversion stoma and/or stenting should be considered as appropriate, for example, in case of obstructive symptomatic disease [IV, A].
View source ↗